243 related articles for article (PubMed ID: 26213845)
1. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract][Full Text] [Related]
2. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.
Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ
Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145
[TBL] [Abstract][Full Text] [Related]
3. N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.
Lane DJ; Saletta F; Suryo Rahmanto Y; Kovacevic Z; Richardson DR
PLoS One; 2013; 8(2):e57273. PubMed ID: 23437357
[TBL] [Abstract][Full Text] [Related]
4. MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
Fang C; Chen YX; Wu NY; Yin JY; Li XP; Huang HS; Zhang W; Zhou HH; Liu ZQ
Sci Rep; 2017 Jan; 7():40384. PubMed ID: 28074905
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
8. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
Liu RY; Dong Z; Liu J; Yin JY; Zhou L; Wu X; Yang Y; Mo W; Huang W; Khoo SK; Chen J; Petillo D; Teh BT; Qian CN; Zhang JT
Oncogene; 2011 Dec; 30(48):4814-23. PubMed ID: 21625209
[TBL] [Abstract][Full Text] [Related]
9. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P
PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.
Shen J; Yin JY; Li XP; Liu ZQ; Wang Y; Chen J; Qu J; Xu XJ; McLeod HL; He YJ; Xia K; Jia YW; Zhou HH
PLoS One; 2014; 9(4):e96008. PubMed ID: 24789280
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
[TBL] [Abstract][Full Text] [Related]
12. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA screening from EIF3a in lung cancer.
Huang MS; Yuan FQ; Gao Y; Liu JY; Chen YX; Wang CJ; He BM; Zhou HH; Liu ZQ
Cancer Med; 2019 Aug; 8(9):4159-4168. PubMed ID: 31197975
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
15. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.
Zhao Y; Li Q; Wu X; Chen P
Mol Med Rep; 2016 Aug; 14(2):1659-66. PubMed ID: 27314502
[TBL] [Abstract][Full Text] [Related]
17. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis.
Qin Y; Li W; Long Y; Zhan Z
Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883
[TBL] [Abstract][Full Text] [Related]
18. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
20. The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients.
Xu X; Han L; Yang H; Duan L; Zhou B; Zhao Y; Qu J; Ma R; Zhou H; Liu Z
Lung Cancer; 2013 Jan; 79(1):65-72. PubMed ID: 23127338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
